Pqq (Pyrroloquinoline Quinone) for Energy And Fatigue

Research suggests that PQQ may support cellular energy production and mitochondrial function through several biological mechanisms, including activation of proteins involved in mitochondrial development such as PGC-1α and TFAM, modulation of NAD-dependent pathways, and antioxidant activity that protects mitochondria from oxidative damage. Studies indicate that these effects span multiple contexts, with a small human crossover trial finding changes in urinary metabolites consistent with improved mitochondrial activity alongside reductions in inflammatory markers, while animal and cell culture studies demonstrate that PQQ can restore mitochondrial function, improve mitochondrial membrane stability, and reduce age-related cellular decline in muscle and other tissues. The available evidence base consists primarily of narrative and mechanistic reviews, in vitro cell studies, and animal experiments, with only one small human trial directly relevant to energy metabolism, which is a meaningful limitation when drawing conclusions about effects in healthy people. Overall, the body of research is directionally consistent in supporting a role for PQQ in mitochondrial and metabolic health, but the scarcity of human clinical trials means that findings remain preliminary and further controlled research is needed to confirm whether these effects translate meaningfully to energy and fatigue outcomes in people.